Video Experimental Relacionado
Updated: Feb 15, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Un marco unificado que combina características moleculares lineales y 3D para la predicción robusta de interacciones
Chang Sun1, Zichen Qin2, Minglei Li1
1Centre for Bioinformatics and Intelligent Medicine, College of Computer Science, Nankai University, Tianjin 300071, China.
Abstract:
We develop PointDPI to predict drug-protein interactions by simultaneously exploiting their linear and 3D structural features. By aligning the features, PointDPI stereoscopically recognizes molecular properties and reduces reliance on 3D structures. Local topological relationships among molecules are further preserved for avoiding distortion. PointDPI predicts key regulatory sites based on the model's gradient. We demonstrate improved performance over several state-of-the-art (SOTA) methods, including increased accuracy in dealing with unseen molecules. Four predicted drug-protein interactions (DPIs) are experimentally validated at both mRNA and protein levels, highlighting the therapeutic potential of adenosine in inflammatory diseases, ondansetron and etodolac in neurological diseases, and neuroprotective action for dopamine.
Videos de Conceptos Relacionados
Predicting Molecular Geometry
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Molecular Chaperones and Protein Folding
The...
Drug toxicity: Drug–Drug Interaction
Pharmacokinetics: Drug–Drug Interactions
Molecular Orbital Theory I

